D. Yin

发表

Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors

Carl W. Miller, D. Xie, K. Black, 2002, Oncogene.

A role for the clock gene per1 in prostate cancer.

S. Gery, H. P. Koeffler, D. Yin, 2009, Cancer research.

Genomic and molecular characterization of esophageal squamous cell carcinoma

Li Shang, Xin Xu, Henry Yang, 2014, Nature Genetics.

Deep sequencing reveals a global reprogramming of lncRNA transcriptome during EMT.

E. Song, K. Hu, D. Yin, 2017, Biochimica et biophysica acta. Molecular cell research.

Cyr61 Is Overexpressed in Gliomas and Involved in Integrin-Linked Kinase-Mediated Akt and β-Catenin-TCF/Lef Signaling Pathways

Dong Xie, Carl W. Miller, Dorina Gui, 2004, Cancer Research.

Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas

Dong Xie, Robert Elashoff, R. Elashoff, 2004, Clinical Cancer Research.

High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray

Martin Dugas, Keith L. Black, Motohiro Kato, 2009, Molecular Cancer Research.

Functional domains of CCN 1 ( Cyr 61 ) regulate breast cancer progression

Carl W. Miller, B. Karlan, H. P. Koeffler, 2022 .

Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through β-Catenin-T-cell Factor/Lef Signaling*

D. Xie, H. Koeffler, Baojie Li, 2007, Journal of Biological Chemistry.

LncRNA DSCAM-AS 1 interacts with YBX 1 to promote cancer progression by 1 forming a positive feedback loop that activates FOXA 1 transcription network 2 3

K. Hu, D. Yin, Hai-yan Yan, 2020 .

LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network

K. Hu, D. Yin, Y. Huang, 2020, Theranostics.

Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator of cell cycle in breast cancer.

K. Hu, H. P. Koeffler, D. Yin, 2017, Oncology reports.

SOX7 is down-regulated in lung cancer

S. Mori, D. Xie, H. P. Koeffler, 2013, Journal of experimental & clinical cancer research : CR.

Reprogramming of m6A epitranscriptome is crucial for shaping of transcriptome and proteome in response to hypoxia

K. Hu, H. Koeffler, D. Yin, 2020, RNA biology.

LCN2-interacting proteins and their expression patterns in brain tumors

Ling Lin, Liyan Xu, Yan Zhao, 2019, Brain Research.

Study on diagnostic value of P1NP and β-CTX in bone metastasis of patients with breast cancer and the correlation between them.

D. Yin, H. Fan, L. Cheng, 2019, European review for medical and pharmacological sciences.

The analyses of SRCR genes based on protein-protein interaction network in esophageal squamous cell carcinoma.

Ling Lin, Zhiyong Wu, Liyan Xu, 2019, American journal of translational research.

AIM-2: A Novel Tumor Antigen is Expressed and Presented by Human Glioma Cells

D. Xie, K. Black, Gentao Liu, 2004, Journal of immunotherapy.

DLK1: increased expression in gliomas and associated with oncogenic activities

D. Xie, K. Black, C. Miller, 2006, Oncogene.

Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme

J. Vadgama, D. Xie, K. Black, 2010, International journal of cancer.

CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.

S. Gery, T. Ikezoe, H. Taguchi, 2005, Cancer research.

Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells

C. Bartram, W. Hofmann, H. Koeffler, 2006, Leukemia.

Dlk1 in normal and abnormal hematopoiesis

L. Shih, W. Hofmann, H. Koeffler, 2005, Leukemia.

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)

K. Hu, D. Yin, Hai-yan Yan, 2013, International journal of oncology.

Dual targeting of glioblastoma with a inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).

D. Yin, Hai-yan Yan, D. Gaut, 2013 .

Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.

K. Black, D. Yin, T. Huynh, 2007, International journal of oncology.

An emerging role of PARK2 in cancer

H. Phillip Koeffler, Liang Xu, D. Yin, 2013, Journal of Molecular Medicine.

Small interference RNA modulation of IL‐10 in human monocyte‐derived dendritic cells enhances the Th1 response

K. Black, Xiangpeng Yuan, Gentao Liu, 2004, European journal of immunology.

Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer

C. Gong, F. Su, E. Song, 2016, EBioMedicine.

Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.

Xiaoping Liu, De-Chen Lin, Benjamin P Berman, 2017, Cancer research.

SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells.

Carl W. Miller, N. Komatsu, N. Kawamata, 2006, Oncology reports.

Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.

R. Okamoto, D. Yin, J. Said, 2009, Cancer research.

Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence

K. Hu, D. Yin, Hai-yan Yan, 2015, Clinical Cancer Research.

Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.

M. Kahn, Ye Chen, Henry Yang, 2015, Cancer research.

Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme

K. Black, D. Yin, D. Lu, 2008, International journal of cancer.

Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells

Dong Xie, Carl W. Miller, Carl Miller, 2005, Clinical Cancer Research.

Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)

K. Black, Gentao Liu, D. Yin, 2005, Oncogene.

Transcription factor NFYA promotes G1/S cell cycle transition and cell proliferation by transactivating cyclin D1 and CDK4 in clear cell renal cell carcinoma.

K. Hu, D. Yin, Yu Li, 2020, American journal of cancer research.

Poly(ADP‐ribosyl)ation of BRD7 by PARP1 confers resistance to DNA‐damaging chemotherapeutic agents

E. Song, Shuangbing Xu, K. Hu, 2019, EMBO reports.

Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma

B. Berman, E. Li, Li-Yan Xu, 2021, Nucleic acids research.

CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.

D. Yin, D. Lu, Li-Fang Peng, 2020, American journal of cancer research.

Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.

K. Black, H. Tai, H. Koeffler, 2008, Cancer research.

ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer

J. Tyner, S. Gery, D. Yin, 2018, Oncogene.

Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells

F. Su, E. Song, Mengfeng Li, 2019, Nature Cell Biology.

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications

D. Yin, Le-hang Lin, Xu Cheng, 2020, Frontiers in Oncology.

ATM‐Dependent Recruitment of BRD7 is required for Transcriptional Repression and DNA Repair at DNA Breaks Flanking Transcriptional Active Regions

E. Song, Yue-Xin Cai, K. Hu, 2020, Advanced science.

Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance

D. Yin, F. Gu, L. Fu, 2012, Breast Cancer Research and Treatment.

Immune Infiltration and Clinical Outcome of Super-Enhancer-Associated lncRNAs in Stomach Adenocarcinoma

D. Yin, Zepeng Du, Xiao-Qing Yuan, 2022, Frontiers in Oncology.

Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers

M. Schummer, B. Karlan, J. Vadgama, 2013, Proceedings of the National Academy of Sciences.

DNA repair gene O6‐methylguanine‐DNA methyltransferase: Promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors

D. Xie, K. Black, W. Hofmann, 2003, Molecular carcinogenesis.

Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis.

B. Karlan, J. Vadgama, A. Leiter, 2011, International journal of oncology.

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme

S. Ogawa, A. Leiter, K. Black, 2013, Oncogene.

SOX7 is down-regulated in lung cancer

S. Mori, D. Xie, P. Tan, 2013, Journal of experimental & clinical cancer research : CR.

FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation.

K. Hu, D. Yin, Hai-yan Yan, 2018, Biochemical and biophysical research communications.

Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1

B. Berman, K. Hu, S. Gery, 2018, Nucleic acids research.

RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT

K. Hu, D. Yin, Yu Li, 2019, Journal of Cancer.

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer

Y. Li, K. Hu, D. Yin, 2016, PloS one.

Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma.

Chunquan Li, D. Yin, D. Lin, 2018, Cancer research.

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells

S. Gery, N. Komatsu, N. Kawamata, 2007, International journal of cancer.

CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes

D. Yin, Jing Zhao, Z. Yao, 2011, Breast Cancer Research and Treatment.

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy

E. Song, D. Yin, Yujie Liu, 2020, JCO precision oncology.

Identification of key genes in osteosarcoma – before and after CDK7 treatment

D. Yin, Qinglong Li, Guoyong Xu, 2021, Medicine.

Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.

Carl W. Miller, H Phillip Koeffler, M. D. Den Boer, 2009, Leukemia research.

Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor: Effects on Gene Expression and Growth of Glioma Cells In vitro and In vivo

Keith L Black, K. Black, N. Kawamata, 2007, Clinical Cancer Research.

Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas

D. Yin, Jian-You Liao, Jie-hua He, 2020, Molecular Cancer.

Imprinting status of DLK1 gene in brain tumors and lymphomas.

Carl W. Miller, S. de Vos, D. Xie, 2004, International journal of oncology.

TMEFF1 and brain tumors

D. Xie, K. Black, H. Koeffler, 2003, Oncogene.

Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo

B. Karlan, T. Haritunians, D. Yin, 2008, Cancer science.

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

H. Yao, F. Su, E. Song, 2018, Nature Communications.

Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF)

P. Thomas Vernier, Jack Weissberg, Fikret Kirkbir, 2012, PloS one.

KLF 6 : Mutational analysis and effect on cancer cell proliferation

Carl W. Miller, K. Black, A. Chumakov, 2022 .

Suppression of Cell Proliferation and Signaling Transduction by Connective Tissue Growth Factor in Non–Small Cell Lung Cancer Cells

A. Marchevsky, D. Yin, A. Mori, 2006, Molecular Cancer Research.

Signaling Pathways-Catenin-TCF / Lef β Integrin-Linked Kinase-Mediated Akt and Cyr 61 Is Overexpressed in Gliomas and Involved in Updated

Carl W. Miller, D. Xie, K. Black, 2004 .

Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells.

T. Haritunians, H. Koeffler, D. Yin, 2008, Leukemia research.

PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity via degradation of phospho-BCL-2

H. Xue, K. Hu, D. Yin, 2020, Theranostics.

Functional domains of CCN1 (Cyr61) regulate breast cancer progression.

Carl W. Miller, B. Karlan, He-jing Wang, 2008, International journal of oncology.

An emerging role of PARK2 in cancer

D. Yin, D. Lin, Liang Xu, 2013, Journal of Molecular Medicine.

Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.

H. Koeffler, D. Yin, D. Lin, 2015, Oncology Report.

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients

H. Yao, F. Su, E. Song, 2018, Nature Communications.

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma

P. Koeffler, D. Yin, D. Lin, 2014, Oncotarget.

Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.

A. Leiter, D. Yin, Weikai Chen, 2010, International Journal of Oncology.